Assessment of Transmission Dynamics of Leprosy in India
Towards understanding the route and dynamics of Leprosy transmission in India
Project start date : 07/11/2018
Last updated : 16/03/2022
Beneficiary country : India
What problem does the initiative address ?
Leprosy, a chronic mycobacterial infection caused by Mycobacterium leprae, is an infectious disease that has ravaged human societies throughout millennia. This pathogen causes disfiguring cutaneous lesions, peripheral nerve injury, osteoarticular deformity, limb loss and dysfunction, blindness and stigma. It affects the skin and peripheral nerves with a wide range of clinical manifestations of long-term nature, including permanent physical disability.
Even though, the Indian Ministry of Health launched The National Leprosy Eradication Programme (NLEP) in 1983, with government funds, India has high leprosy incidence and in 2016 contributed to about 63% of the global burden. Annual New Case Detection Rate (ANCDR) is 10.17 per 100,000 populations.
Despite ongoing efforts in interrupting leprosy transmission, large numbers of new cases are persistently identified in many endemic areas. Moreover, at the time of diagnosis, most newly identified cases have a considerable neurologic disability. Many challenges remain in our understanding of the epidemiology of leprosy including: the precise mode and route of transmission; the socioeconomic, environmental, and behavioral factors that promote its transmission; strategies to achieve early diagnosis and prevent neurologic impairment to reduce the large burden of disability among newly identified cases and among those who endure long-term disability despite completing multidrug therapy.
Detailed description of the initiative
The current application developed for NLEP captures case-based data which can be aggregated at various levels i.e.: District, State, and National levels real time for analysis by the national team and to make effective policy decisions. The current leprosy information system captures demographic details of the patient as well as the history of migration which will come in handy in understanding the dynamics of the disease. The application allows classification of the case into PB and MB case based on the symptoms entered (i.e. peripheral nerves involved, nodules, etc.). The details of contact tracing, antibiotics given, and the status of treatment are being entered for all the patients. All the states are currently entering data at the Block level since April 2018.
What is the proposed solution added value ?
Historically, the surveillance system has been paper-based or based on Excel sheets. HISP India’s objective is to strengthen and modernize the surveillance system. This requires a flexible information system responsive to the needs of NLEP towards understanding the dynamics in the disease transmission.
3 275
Number of beneficiaries since launch
1 Full-Time equivalents
4 Employees
N/C Volunteers
1 Service providers
3 275
Number of beneficiaries since launch
Target audience
- Healthcare professionals and structures (hospitals, healthcare centres/clinics, health networks)
- Entire population
- Sick people
- Dependents/persons with disabilities
- Patient family/entourage
Project objectives
- Decreased mortality
- Decreased morbidity
- Reduced suffering
- Improved treatment
Materials used
- Computer
Technologies used
- Mobile telecommunications (without data connection)
- Internet
- Geolocation
Offline use
Yes
Open source
Yes
Open data
No
Independent evaluation
Yes, auto-evaluated or evaluated by a related organization
About the sponsor
Society for Health Information Systems Programmes, India, (HISP India)
The Society for Health Information Systems Programmes, India (HISP India) is a registered not for profit society and a node in the global HISP network and active contributor to the DHIS community. With a base in India, HISP India is supporting multiple regional (South Asia) implementations of DHIS2, while strongly embedded in supporting health information systems in the Indian States and South East Asia Region.
HISP India has a primary focus on strengthening public health systems in India, and as an active member of the global HISP network has also worked in national health systems strengthening in various countries in the region, including Nepal, Bangladesh, Bhutan, Sri Lanka, Indonesia, and Tajikistan. HISP India has in collaborative MoU with the University of Oslo (UiO) which enables collaboration on DHIS2 based HMIS implementation projects in countries such as Nepal, Indonesia, and is currently working with UiO, PATH Zambia, Plan International and ICMR (Indian Council of Medical research) on many research projects including National Leprosy Monitoring system. HISP India is currently working with WHO India on projects relating to LF and Leprosy surveillance through SMS reporting.
HISP India team is part of the DHIS2 implementer group who are being trained on the WHO Health App which contains the WHO defined applications on TB program standard aggregate and tracker based data collection programs, Immunization registry, Malaria standard aggregate and tracker programs, and Data management systems for Cause of Death and HIV.
Sector : Institutions (Communities, public authorities, NGOs, foundations, etc.)
Country of origin :
Contact : Sponsor website Project website
Partners
-
University of Oslo
Academic entities (Universities, research laboratories, etc)
-
Indian Council of Medical Research
Academic entities (Universities, research laboratories, etc)
-
World Health Organisation
Institutions (Communities, public authorities, NGOs, foundations, etc.)